ema prac naion semaglutide very rare side effect 2025 Meeting highlights from the Pharmacovigilance Risk Assessment Committee ( PRAC) 2-5 June Does Ozempic really cause blindness?”

This guide provides evidence-based recommendations aligned with MHRA guidance and UK best practice

This can be your primary care doctor, an endocrinologist, an obesity medicine specialist, or a telehealth provider

Well continue to track all of our patients with surveys and follow up appointments to get the most complete picture of weight loss, but the initial results are very exciting

A 2025 narrative review by Varughese and colleagues describes the broader animal-data picture for GLP-1 receptor agonists: decreased fetal weight, delayed bone formation, skeletal variants, and visceral abnormalities in animals exposed during gestation

Customized treatment plans for optimal results